Diagnosis of Liver Cysts – Evidence‑Based Guideline Summary

Initial Diagnostic Approach

• Ultrasound is the first‑line and definitive imaging modality for simple hepatic cysts; once typical features are identified, further CT or MRI is not required. (European Association for the Study of the Liver [EASL] recommendation, 96 % consensus) 1
• Ultrasound should be used as the primary imaging test for any suspected liver cyst, whether discovered incidentally or in patients with symptoms. (EASL 96 % consensus; also endorsed by the American Association for the Study of Liver Diseases) 2
• Ultrasound demonstrates approximately 90 % sensitivity and specificity for diagnosing simple hepatic cysts. (EASL) 1

Imaging When Simple Features Are Absent

• If ultrasound reveals complex characteristics (e.g., internal septations, mural thickening or nodularity, debris‑containing fluid, wall enhancement, or calcifications), contrast‑enhanced MRI—not CT—should be obtained for further characterization. (American College of Radiology guidance) 3

Polycystic Liver Disease (PLD)

• PLD is diagnosed when more than ten hepatic cysts are identified on any imaging modality (ultrasound, CT, or MRI). (EASL) 2
• MRI is preferred over ultrasound and CT for detecting small cysts, especially in younger patients and those with renal insufficiency. (EASL) 2

Suspected Hemorrhagic Cyst

• Initial evaluation should start with ultrasound to look for heterogeneous hyperechoic mobile material and thin mobile septations suggestive of intracystic clot. (EASL) 4
• If ultrasound findings are equivocal, contrast‑enhanced MRI should be performed; hemorrhagic cysts appear heterogeneous and hyperintense on both T1‑ and T2‑weighted sequences. (EASL) 4
• CT is not recommended for detecting intracystic hemorrhage because of low reliability. (EASL, strong recommendation, 91 % consensus) 4

Suspected Infected Cyst

• When infection is suspected (fever > 38.5 °C for > 3 days with abdominal tenderness), obtain contrast‑enhanced CT or MRI (ultrasound alone is insufficient). (EASL) 4
• Imaging signs of infection include enhanced wall thickening, perilesional inflammation, or the presence of gas within the cyst. (EASL) 4

Caroli Disease

• Magnetic resonance cholangiopancreatography (MRCP) should be performed when imaging shows segmental intra‑hepatic cystic dilatations. (EASL) 1
• MRCP provides the highest diagnostic accuracy by visualizing the biliary tree and demonstrating continuity between cystic lesions and draining bile ducts. (EASL) 2

Common Pitfalls to Avoid

• Do not order CT or MRI after ultrasound confirms a simple cyst; this adds unnecessary cost without improving outcomes. (EASL) 1
• Do not use CT to diagnose cyst hemorrhage; CT is unreliable for this purpose. (EASL, strong recommendation, 91 % consensus) 4
• Do not rely solely on imaging to differentiate infected from hemorrhagic cysts; clinical correlation with fever, pain pattern, and laboratory markers is essential. (EASL) 4

Diagnostic Approach for Hepatic Cysts

Imaging Recommendations

• The American Association for the Study of Liver Diseases recommends ultrasound as the first-line diagnostic modality for suspected hepatic cysts, with approximately 90% sensitivity and specificity for diagnosis 5, 6
• Simple hepatic cysts appear as round or oval-shaped, anechoic lesions with sharp, smooth borders, thin walls, and strong posterior acoustic enhancement 5
• Once a simple cyst is confirmed on ultrasound, no further imaging (CT or MRI) is indicated, as recommended by the European Association for the Study of the Liver (EASL) 5, 6
• MRI with contrast-enhanced sequences should be ordered when ultrasound shows complex features, including septations, mural thickening or nodularity, debris-containing fluid, wall enhancement, or calcifications, according to the American College of Radiology 5, 6
• Contrast-enhanced ultrasound (CEUS) can be used for complex cysts to identify vascularized septation or wall enhancement, which distinguishes malignant from benign lesions, as stated by the World Federation for Ultrasound in Medicine and Biology 5, 6

Bloodwork and Laboratory Testing

• The European Association for the Study of the Liver (EASL) guidelines explicitly state that no bloodwork is required for asymptomatic simple hepatic cysts, as these are benign developmental anomalies 7
• Tumor markers (CEA and CA19-9) should not be ordered for hepatic cysts, as they cannot reliably distinguish benign cysts from malignant lesions, according to the National Comprehensive Cancer Network (NCCN) 7
• If clinical features suggest infected hepatic cyst, complete blood count and C-reactive protein (CRP) should be ordered to assess for leukocytosis and inflammation, as recommended by the Infectious Diseases Society of America (IDSA) 7

Specific Diagnostic Scenarios

• Diagnosis of polycystic liver disease is made when >10 hepatic cysts are present on imaging, and renal function testing is mandatory to evaluate for concurrent autosomal dominant polycystic kidney disease (ADPKD), according to the American Association of Clinical Endocrinologists (AACE) 5, 6, 7
• Magnetic resonance cholangiopancreatography (MRCP) provides the highest diagnostic accuracy for visualizing the biliary tree and confirming the diagnosis of Caroli disease, as stated by the Society of Abdominal Radiology 5, 6

Screening and Management of Hepatic Cysts

Primary Screening Modality

• Ultrasound is the definitive first‑line screening test for hepatic cysts; when typical simple‑cyst features are identified, further CT or MRI imaging is unnecessary. Strong EASL recommendation (96 % consensus). 8
• The European Association for the Study of the Liver (EASL) strongly recommends using ultrasound as the primary screening tool for any suspected liver cyst, whether incidentally discovered or symptomatic, with 100 % consensus. 8
• Ultrasound provides approximately 90 % sensitivity and specificity for detecting hepatic cysts. Evidence level: high diagnostic accuracy. 9
• Ultrasound is widely available, inexpensive, free of ionising radiation, and can reliably assess cyst content and wall thickness. Practical advantage noted by EASL. 9

Criteria for Additional Imaging

• If ultrasound reveals complex cyst characteristics—such as internal septations, mural thickening or nodularity, debris‑containing fluid, wall enhancement, or hemorrhagic/proteinaceous contents—contrast‑enhanced MRI (not CT) should be obtained for further characterization. Strong EASL recommendation (96 % consensus). 9
• Contrast‑enhanced ultrasound (CEUS) may be employed for complex cysts to detect vascularised septations or wall enhancement, aiding differentiation between benign and malignant lesions. Evidence level: moderate. 9

Polycystic Liver Disease (PLD)

• PLD is defined by the presence of more than ten hepatic cysts on any imaging modality (ultrasound, CT, or MRI). Diagnostic criterion per EASL. 9
• MRI is the preferred modality for detecting small cysts in PLD, especially in younger patients and those with renal insufficiency, because of its superior sensitivity. Strong recommendation. 9
• In asymptomatic PLD without complications, no imaging beyond the initial diagnostic study is required. Evidence level: low‑to‑moderate. 9

Biliary Hamartomas

• MRI with heavily T2‑weighted sequences and MR cholangiography is the imaging modality of choice for diagnosing biliary hamartomas. EASL guideline. 8
• On MRI, biliary hamartomas appear as multiple small (2–10 mm) hyperintense lesions producing a “starry‑sky” appearance. Descriptive imaging finding. 10

Follow‑Up Recommendations

• Routine surveillance of asymptomatic patients with simple hepatic cysts, biliary hamartomas, or peribiliary cysts is not recommended; imaging follow‑up should be reserved for the development of symptoms. Strong EASL recommendation (96 % consensus). 10
• After therapeutic interventions such as aspiration‑sclerotherapy or surgical resection, routine follow‑up imaging is unnecessary; treatment success is defined by symptom relief rather than cyst volume reduction. Evidence level: moderate. 10